Early recurrence after pulmonary vein isolation of paroxysmal atrial fibrillation with different ablation technologies: Prospective comparison of radiofrequency vs. second-generation cryoballoon ablation

Circulation Journal

Volumn 80, Issue 2, 2016, Pages 346-353

  Miyazaki, Shinsuke ^a   Kuroi, Akio ^a   Hachiya, Hitoshi ^a   Nakamura, Hiroaki ^a   Taniguchi, Hiroshi ^a   Ichihara, Noboru ^a   Takagi, Takamitsu ^a   Iwasawa, Jin ^a   Iesaka, Yoshito ^a  

^a TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

Author keywords

Atrial fibrillation; Catheter ablation; Cryoballoon; Early recurrence; Pulmonary vein isolation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ABLATION CATHETER; ABLATION THERAPY; ADULT; ARTICLE; BLOOD ANALYSIS; BODY TEMPERATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYOBALLOON ABLATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GUIDE WIRE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAROXYSMAL ATRIAL FIBRILLATION; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; AGED; ATRIAL FIBRILLATION; BLOOD; CATHETER ABLATION; CLINICAL TRIAL; COMPARATIVE STUDY; CRYOSURGERY; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY VEIN;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CRYOSURGERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY VEINS;

EID: 84955468717     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-1051     Document Type: Article

References (28)

1. Haïssaguerre M, Jaïs P, Shah DC, Garrigue S, Takahashi A, Lavergne T, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-1417.
2. Kojodjojo P, O’Neill MD, Lim PB, Malcolm-Lawes L, Whinnett ZI, Salukhe TV, et al. Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: Medium-term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation. Heart 2010; 96: 1379-1384.
3. Andrade JG, Khairy P, Macle L, Packer DL, Lehmann JW, Holcomb RG, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: Insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol 2014; 7: 69-75.
4. Koyama T, Tada H, Sekiguchi Y, Arimoto T, Yamasaki H, Kuroki K, et al. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: A randomized controlled trial. J Am Coll Cardiol 2010; 56: 1463-1472.
5. Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, et al. Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol 2012; 101: 217-225.
6. Lim HS, Schultz C, Dang J, Alasady M, Lau DH, Brooks AG, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 2014; 7: 83-89.
7. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2012; 9: 632-696.
8. Ichihara N, Miyazaki S, Taniguchi H, Usui E, Takagi T, Iwasawa J, et al. Simple minimal sedation for catheter ablation of atrial fibrillation. Circ J 2015; 79: 346-350.
9. Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, et al. Long-term clinical outcome of extensive pulmonary vein isolation- based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation. Heart 2011; 97: 668-673.
10. Miyazaki S, Taniguchi H, Nakamura H, Takagi T, Iwasawa J, Hachiya H, et al. Clinical significance of early recurrence after pulmonary vein antrum isolation in paroxysmal atrial fibrillation: Insight into the mechanism. Circ J 2015; 79: 2353-2359.
11. Miyazaki S, Taniguchi H, Kusa S, Uchiyama T, Nakamura H, Hachiya H, et al. Impact of atrial fibrillation termination site and termination mode in catheter ablation on arrhythmia recurrence. Circ J 2014; 78: 78-84.
12. Miyazaki S, Hachiya H, Taniguchi H, Nakamura H, Ichihara N, Usui E, et al. Prospective evaluation of bilateral diaphragmatic electromyograms during cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2015; 26: 622-628.
13. Miyazaki S, Taniguchi H, Nakamura H, Hachiya H, Ichihara N, Araki M, et al. Adenosine triphosphate test after cryothermal pulmonary vein isolation: Creating contiguous lesions is essential for eliminating dormant conduction. J Cardiovasc Electrophysiol 2015; 26: 1069-1074.
14. Takagi T, Miyazaki S, Kusa S, Taniguchi H, Ichihara N, Iwasawa J, et al. Role of extended external auto-triggered loop recorder monitoring for atrial fibrillation: Validation and utility after catheter ablation procedures. Circ J 2014; 78: 2637-2642.
15. Schmidt M, Marschang H, Clifford S, Harald R, Guido R, Oliver T, et al. Trends in inflammatory biomarkers during atrial fibrillation ablation across different catheter ablation strategies. Int J Cardiol 2012; 158: 33-38.
16. Bordignon S, Fürnkranz A, Dugo D, Perrotta L, Gunawardene M, Bode F, et al. Improved lesion formation using the novel 28 mm cryoballoon in atrial fibrillation ablation: Analysis of biomarker release. Europace 2014; 16: 987-993.
17. Coulombe N, Paulin J, Su W. Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. J Cardiovasc Electrophysiol 2013; 24: 919-925.
18. Malmborg H, Lönnerholm S, Blomström P, Blomström-Lundqvist C. Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: A randomized controlled study comparing the clinical outcome and safety; the AFCOR study. Europace 2013; 15: 1567-1573.
19. Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: A review. Expert Rev Cardiovasc Ther 2013; 11: 55-59.
20. Grubman E, Pavri BB, Lyle S, Reynolds C, Denofrio D, Kocovic DZ. Histopathologic effects of radiofrequency catheter ablation in previously infarcted human myocardium. J Cardiovasc Electrophysiol 1999; 10: 336-342.
21. Rodriguez LM, Leunissen J, Hoekstra A, Korteling BJ, Smeets JL, Timmermans C, et al. Transvenous cold mapping and cryoablation of the AV node in dogs: Observations of chronic lesions and comparison to those obtained using radiofrequency ablation. J Cardiovasc Electrophysiol 1998; 9: 1055-1061.
22. Deneke T, Khargi K, Müller KM, Lemke B, Mügge A, Laczkovics A, et al. Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J 2005; 26: 1797-1803.
23. Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003; 107: 2045-2050.
24. Dubuc M, Roy D, Thibault B, Ducharme A, Tardif JC, Villemaire C, et al. Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs. Pacing Clin Electrophysiol 1999; 22: 1488-1498.
25. Oswald H, Gardiwal A, Lissel C, Yu H, Klein G. Difference in humoral biomarkers for myocardial injury and inflammation in radiofrequency ablation versus cryoablation. Pacing Clin Electrophysiol 2007; 30: 885-890.
26. Hernández-Romero D, Marín F, Roldán V, Peñafiel P, Vilchez JA, Orenes-Piñero E, et al. Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation. Pacing Clin Electrophysiol 2013; 36: 31-36.
27. Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G, et al. Single 3-minute freeze for second-generation cryoballoon ablation: One-year follow-up after pulmonary vein isolation. Heart Rhythm 2015; 12: 673-680.
28. Takami M, Lehmann HI, Misiri J, Parker KD, Sarmiento RI, Johnson SB, et al. The impact of freezing time and balloon size on the thermodynamics and isolation efficacy during pulmonary vein isolation using the 2nd generation cryoballoon. Circ Arrhythm Electrophysiol 2015; 8: 836-845.